A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Clinical trial NCT07771465 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07771465
Sponsor: Kardigan, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Symptomatic Genetic Dilated Cardiomyopathy (DCM)

Start date: 2026-08-01
Primary completion: 2032-11-01
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.